Tenet Healthcare exec converts 3,800 RSUs to stock

TENET HEALTHCARE CORP executive Thomas W. Arnst reported equity-based compensation activity.

Rhea-AI Filing Summary

TENET HEALTHCARE CORP executive Thomas W. Arnst reported equity-based compensation activity. On February 24, 2026, 3,800 of his 2025 Restricted Stock Units were exercised and converted into 3,800 shares of common stock at a stated price of $0.00 per share.

The units were granted under the 2019 Stock Incentive Plan on February 24, 2025 and vest in three equal annual installments; the first one-third vested on February 24, 2026. After these transactions, he directly holds 7,602 restricted stock units and 41,585 shares of common stock.

Insider Trade Summary

3,800 shares exercised/converted

Exercise 2 txns

Insider Arnst Thomas W

Role EVP, Chief Admin. Officer & GC

Type	Security	Shares	Price	Value
Exercise	2025 Restricted Stock Units	3,800	$0.00	$0.00
Exercise	Common Stock	3,800	$0.00	$0.00

Holdings After Transaction: 2025 Restricted Stock Units — 7,602 contracts (Direct); Common Stock — 41,585 shares (Direct)

Footnotes (3)

1. F1. Restricted stock units convert into common stock on a one-for-one basis.
2. F2. The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 24, 2025, vest equally in 1/3 increments on the first, second and third anniversaries of the grant date, and the first 1/3 increment vested on February 24, 2026.
3. F3. Time-based restricted stock units are settled in shares of the Company's common stock upon vesting.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did THC executive Thomas W. Arnst report?

Thomas W. Arnst reported the vesting and conversion of 3,800 Restricted Stock Units into 3,800 shares of Tenet Healthcare common stock at a stated price of $0.00 per share, reflecting routine equity compensation rather than an open-market stock purchase or sale.

How many Tenet Healthcare (THC) shares does Thomas W. Arnst hold after this Form 4?

After the reported transactions, Thomas W. Arnst directly holds 41,585 shares of Tenet Healthcare common stock. He also continues to hold 7,602 restricted stock units that remain outstanding, which may convert into additional common shares as they vest over time.

Were the Tenet Healthcare (THC) insider transactions open-market buys or sells?

The transactions were not open-market buys or sells. They reflect an exercise and conversion of 3,800 Restricted Stock Units into common stock at a stated price of $0.00, consistent with time-based vesting under Tenet Healthcare’s 2019 Stock Incentive Plan.

What is the vesting schedule for Thomas W. Arnst’s 2025 Tenet Healthcare RSUs?

The 2025 Restricted Stock Units were granted on February 24, 2025 and vest in three equal one-third installments on the first, second, and third anniversaries of that grant date. The first one-third portion vested on February 24, 2026 and was settled in common stock.

Under which plan were Thomas W. Arnst’s Tenet Healthcare RSUs granted?

The Restricted Stock Units reported in this Form 4 were granted under Tenet Healthcare’s 2019 Stock Incentive Plan. These time-based RSUs are designed to vest over three years and are settled in shares of the company’s common stock upon each vesting date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/26/2026 - 08:00 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Arnst Thomas W

(Last) (First) (Middle)

14201 DALLAS PARKWAY

(Street)

DALLAS TX 75254

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
TENET HEALTHCARE CORP [ THC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, Chief Admin. Officer & GC

3. Date of Earliest Transaction (Month/Day/Year)
02/24/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/24/2026		M		3,800	A	(1)	41,585	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
2025 Restricted Stock Units	(2)	02/24/2026		M			3,800	(2)	(2)	Common Stock(3)	3,800	$0	7,602	D

Explanation of Responses:

1. Restricted stock units convert into common stock on a one-for-one basis.

2. The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 24, 2025, vest equally in 1/3 increments on the first, second and third anniversaries of the grant date, and the first 1/3 increment vested on February 24, 2026.

3. Time-based restricted stock units are settled in shares of the Company's common stock upon vesting.

	Chad J. Wiener, as Attorney-in-fact for Thomas W. Arnst	02/26/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.